Point72 Europe’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-87,564
Closed -$7.04M 768
2025
Q2
$7.04M Sell
87,564
-9,100
-9% -$702K 0.27% 84
2025
Q1
$7.76M Sell
96,664
-21,200
-18% -$1.76M 0.53% 65
2024
Q4
$9.65M Buy
+117,864
New +$9.81M 0.56% 54
2024
Q2
Sell
-116,400
Closed -$8.63M 153
2024
Q1
$8.63M Buy
116,400
+16,629
+17% +$1.16M 0.77% 51
2023
Q4
$6.6M Sell
99,771
-13,629
-12% -$853K 0.83% 42
2023
Q3
$7.13M Sell
113,400
-16,500
-13% -$1.03M 0.44% 41
2023
Q2
$7.34M Sell
129,900
-1,500
-1% -$83.2K 0.96% 36
2023
Q1
$7.61M Sell
131,400
-26,900
-17% -$1.82M 1.66% 20
2022
Q4
$11.5M Sell
158,300
-1,800
-1% -$129K 2.89% 12
2022
Q3
$9.73M Buy
160,100
+4,900
+3% +$313K 1.48% 15
2022
Q2
$9.74M Buy
155,200
+3,700
+2% +$245K 2.06% 18
2022
Q1
$10.6M Buy
151,500
+3,800
+3% +$257K 1.82% 12
2021
Q4
$9.23M Sell
147,700
-1,000
-0.7% -$62.8K 4.22% 9
2021
Q3
$9.18M Buy
148,700
+24,600
+20% +$1.48M 4.64% 8
2021
Q2
$7.43M Buy
124,100
+24,700
+25% +$1.57M 5.13% 10
2021
Q1
$6.04M Buy
+99,400
New +$5.49M 3.81% 12
2017
Q3
Sell
-176,827
Closed -$8.66M 61
2017
Q2
$8.66M Buy
+176,827
New +$8.2M 2.05% 11

Other funds holding MET

Point72 Europe's MET Position: Q3 2025 in Review

Point72 Europe sold out of MetLife (MET) in Q3 2025, closing a stake of 87,564 shares — an estimated $7.04M sold.

Point72 Europe first reported a position in MET in Q2 2017 and held it in 17 quarters. The position peaked at $11.5M in Q4 2022. 1,368 funds tracked by Wall St. Rank hold MET as of Q3 2025.

  • Point72 Europe reported no remaining MetLife position as of Q3 2025 after selling out during the quarter.
  • Point72 Europe sold 87,564 MetLife shares in Q3 2025, an estimated $7.04M.
  • Point72 Europe first reported a position in MetLife in Q2 2017 and held it in 17 quarters.
  • Point72 Europe's MetLife position peaked at $11.5M in Q4 2022.
  • 1,368 funds tracked by Wall St. Rank held MetLife as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.